LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
Преглед
Промяна на цената на акция
24 ч
Текуща
Минимум
82.94
Максимум
83.26
Препоръки | Силна покупка |
---|---|
12-месечна прогноза | +6.27 upside |
Техническа оценка
By Trading Central
Увереност
Very Strong Bearish Evidence
82.46 / 87.21 Подкрепа & съпротива
AstraZeneca PLC ADR Графика
Свързани новини
25.07.2024 г., 09:17 ч. UTC
AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update
DJ
Прочетени
25.07.2024 г., 06:48 ч. UTC
AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations
DJ
Прочетени
12.07.2024 г., 19:57 ч. UTC
Instil Bio Shares Surge Following Rental Agreement with AstraZeneca
DJ
Прочетени
5.09.2024 г., 13:00 ч. UTC
China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ
DJ
Прочетени
29.07.2024 г., 10:30 ч. UTC
Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ
DJ
Прочетени
25.07.2024 г., 13:20 ч. UTC
AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD
DJ
Прочетени
25.07.2024 г., 09:21 ч. UTC
AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk
DJ
Прочетени
25.07.2024 г., 07:05 ч. UTC
AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk
DJ
Прочетени
25.07.2024 г., 06:06 ч. UTC
AstraZeneca Increased Interim Dividend by 7c to $1.00
DJ
Прочетени
25.07.2024 г., 06:04 ч. UTC
AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range
DJ
Прочетени
25.07.2024 г., 06:04 ч. UTC
AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range
DJ
Прочетени
25.07.2024 г., 06:04 ч. UTC
AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency
DJ
Прочетени
25.07.2024 г., 06:04 ч. UTC
AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency
DJ
Прочетени
25.07.2024 г., 06:03 ч. UTC
AstraZeneca Raises 2024 View
DJ
Прочетени
25.07.2024 г., 06:02 ч. UTC
AstraZeneca 2Q Revenue Consensus Was $12.7B
DJ
Прочетени
25.07.2024 г., 06:02 ч. UTC
AstraZeneca 2Q Core EPS Consensus Was $1.95
DJ
Прочетени
25.07.2024 г., 06:00 ч. UTC
AstraZeneca PLC 2Q Adj EPS $1.98
DJ
Прочетени
25.07.2024 г., 06:00 ч. UTC
AstraZeneca PLC 2Q Pretax Pft $2.4B
DJ
Прочетени
25.07.2024 г., 06:00 ч. UTC
AstraZeneca PLC 2Q Rev $12.94B
DJ
Прочетени
25.07.2024 г., 06:00 ч. UTC
AstraZeneca PLC 2Q Oper Pft $2.75B
DJ
Прочетени
25.07.2024 г., 06:00 ч. UTC
AstraZeneca PLC 2Q Net Pft $1.93B
DJ
Прочетени
25.07.2024 г., 06:00 ч. UTC
AstraZeneca PLC 2Q EPS $1.24
DJ
Прочетени
15.07.2024 г., 06:04 ч. UTC
AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone
DJ
Прочетени
15.07.2024 г., 06:04 ч. UTC
AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone
DJ
Прочетени
15.07.2024 г., 06:02 ч. UTC
AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing
DJ
Прочетени
15.07.2024 г., 06:02 ч. UTC
AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B
DJ
Прочетени
15.07.2024 г., 06:01 ч. UTC
AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline
DJ
Прочетени
15.07.2024 г., 06:00 ч. UTC
AstraZeneca Completes Acquisition of Amolyt Pharma
DJ
Прочетени
15.07.2024 г., 06:00 ч. UTC
AstraZeneca PLC Acquisition of Amolyt Pharma completed
DJ
Прочетени
15.07.2024 г., 06:00 ч. UTC
AstraZeneca PLC Acquisition of Amolyt Pharma completed
DJ
Прочетени
Сравнение с други в отрасъла
Ценова промяна
AstraZeneca PLC ADR Прогноза
Ценова цел
By TipRanks
12-месечна прогноза
Среден 88.26 USD 6.27%
Висок 99 USD
Нисък 74 USD
Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за AstraZeneca PLC ADR през последните три месеца.
Консенсусна оценка
By TipRanks
Силна покупка
6 ratings
5
Купи
1
Задържане
0
Продай
Според 6 анализатори, дали борсови рейтинги на AstraZeneca PLC ADR през последните 3 месеца.
Техническа оценка
By Trading Central
Краткосрочен план
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Средносрочен план
Bearish Evidence
Recent bearish events outweigh bullish events.
Дългосрочен план
No Evidence
There are no events.